These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14906886)

  • 1. [Chloroalkylamines and acute leukemia; clinical and histopathological study of methyl-bis (beta chloroethyl) amine hydrochloride in acute hemocytoblastic leukosis].
    MARINONE G
    Haematologica; 1951; 35(11):993-1041. PubMed ID: 14906886
    [No Abstract]   [Full Text] [Related]  

  • 2. [P-bis-(beta-chloroethyl) aminophenylalanine (sarcolysin) in antiblastic chemotherapy with special reference to lymphatic blood diseases].
    LOVISETTO P; CASTELLANO M
    Haematologica; 1958; 43(4):261-324. PubMed ID: 13548671
    [No Abstract]   [Full Text] [Related]  

  • 3. Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.
    Goodman LS; Wintrobe MM; Dameshek W; Goodman MJ; Gilman A; McLennan MT
    JAMA; 1984 May; 251(17):2255-61. PubMed ID: 6368885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protective effect of beta-mercaptoethylamine against the toxic effects on plant cells of a nitrogen oxidized nitrogen mustard, methyl bis-(beta-chlorethyl) amine N-oxide hydrochloride].
    DEYSSON G; TRUHAUT R
    C R Hebd Seances Acad Sci; 1954 Apr; 238(17):1725-7. PubMed ID: 13161244
    [No Abstract]   [Full Text] [Related]  

  • 5. [The hydrochloride of 2,2'-dichloro-N-methyldiethylamine N-oxide in the therapy of malignant blood diseases].
    CONSOLI G
    G Ital Chemioter; 1954; 1(1):154-6. PubMed ID: 13191611
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms].
    INGRASSIA G; VASILE B
    Haematologica; 1951; 35(10):907-53. PubMed ID: 14906882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trial therapy of leukoses, lymphogranulomas & malignant tumors with urethane, chloroethylamine & other clinical compounds].
    CHILOV K; IVANOV S; KIRCHEV P
    Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1957; 14():73-129. PubMed ID: 13587006
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical changes in induced cytolysis].
    HELLENDOORN HB; PELT M; GERBRANDY J
    Ned Tijdschr Geneeskd; 1957 Jun; 101(22):1056-8. PubMed ID: 13451760
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of estradiol phenol bis (2-chloroethyl) carbamate in advanced breast cancer].
    Eur J Cancer (1965); 1969 Feb; 5(1):1-4. PubMed ID: 5780170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic procedures for ambulatory treatment of hemoblastosis and malignant neoplasms].
    SZENTKLARAY J
    Neoplasma; 1958; 5(1):62-73. PubMed ID: 13552896
    [No Abstract]   [Full Text] [Related]  

  • 11. [New way of synthetizing 4-/N,N-bis-(chloroethyl)-amino/-phenyl-beta-D-glucopyranosiduronic acid methyl ester].
    Schwabe K; Tschiersch B; Arndt D
    Pharmazie; 1977 Jan; 32(1):52-3. PubMed ID: 840886
    [No Abstract]   [Full Text] [Related]  

  • 12. A method of evaluation of quality of 4-methyl-5-(bis-(beta-chloroethyl)-amino)-uracil.
    Grabowska I; Kaliszan R; Kuciński W
    Pol J Pharmacol Pharm; 1973; 25(6):621-6. PubMed ID: 4792485
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with BCM (degranol) beta-bis-chlorethylamino-D-mannitoldichlorhydrate].
    ECKHARDT A; SELLEI C; MOLNAR A; HARTAI F
    Krebsarzt; 1958 Feb; 13(2):73-5. PubMed ID: 13540175
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of chlorpromazine in the treatment of vomiting caused by methyl-bis-(beta-chlorethyl)amine].
    MORINI A
    Riforma Med; 1958 May; 72(21):577-8. PubMed ID: 13568480
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with the use of p-(N,N-di-2-chloroethyl) aminophenylbutyric acid in the chemotherapy of various hemolymphoblastoses].
    FUSCO FA
    Prog Med (Napoli); 1958 Feb; 14(3):73-84. PubMed ID: 13542661
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical application of a nitrogen mustard compound methyl bis (beta-chloroethyl) amine to the treatment of neoplastic disorders of the hemopoietic system.
    SPURR CL; JACOBSON LO
    Cancer Res; 1947 Jan; 7(1):51. PubMed ID: 20278230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protective effect of sodium hyposulfite against tri(beta-chloroethyl) amine (HN3) in rats].
    PAOLETTI C; BOIRON M; TRUHAUT R; BERNARD J
    C R Seances Soc Biol Fil; 1957; 151(4):643-6. PubMed ID: 13489938
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of the clinical use of asalin].
    Kruglova GV
    Vopr Onkol; 1965; 11(10):10-6. PubMed ID: 5872964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the injection of methylbis(beta-chloroethyl) amine (caryolisine) on Ehrlich's experimental ascitic cancer].
    PELLET M; BROSSON J
    Lyon Med; 1961 Aug; 93():287-92. PubMed ID: 13734003
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic targets in the nitrogen mustard sensitivity of B-cell chronic lymphocyte leukemia (B-CLL).
    Kannan S
    Med Hypotheses; 2006; 67(4):998. PubMed ID: 16757124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.